Your browser doesn't support javascript.
loading
Population Pharmacokinetic-B Cell Modeling for Ofatumumab in Patients with Relapsing Multiple Sclerosis.
Yu, Huixin; Graham, Gordon; David, Olivier J; Kahn, Joseph M; Savelieva, Marina; Pigeolet, Etienne; Das Gupta, Ayan; Pingili, Ratnakar; Willi, Roman; Ramanathan, Krishnan; Kieseier, Bernd C; Häring, Dieter A; Bagger, Morten; Soelberg Sørensen, Per.
Affiliation
  • Yu H; Novartis Pharma AG, Postfach CH-4002, Basel, Switzerland.
  • Graham G; Novartis Pharma AG, Postfach CH-4002, Basel, Switzerland. gordon.graham@novartis.com.
  • David OJ; Novartis Pharma AG, Postfach CH-4002, Basel, Switzerland.
  • Kahn JM; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Savelieva M; Novartis Pharma AG, Postfach CH-4002, Basel, Switzerland.
  • Pigeolet E; Novartis Pharma AG, Postfach CH-4002, Basel, Switzerland.
  • Das Gupta A; Novartis Healthcare Pvt. Ltd., Hyderabad, India.
  • Pingili R; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Willi R; Novartis Pharma AG, Postfach CH-4002, Basel, Switzerland.
  • Ramanathan K; Novartis Pharma AG, Postfach CH-4002, Basel, Switzerland.
  • Kieseier BC; Novartis Pharma AG, Postfach CH-4002, Basel, Switzerland.
  • Häring DA; Department of Neurology, Medical Faculty, Heinrich-Heine University, Duesseldorf, Germany.
  • Bagger M; Novartis Pharma AG, Postfach CH-4002, Basel, Switzerland.
  • Soelberg Sørensen P; Novartis Pharma AG, Postfach CH-4002, Basel, Switzerland.
CNS Drugs ; 36(3): 283-300, 2022 03.
Article in En | MEDLINE | ID: mdl-35233753

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Sclerosis Type of study: Prognostic_studies Limits: Adult / Humans Language: En Journal: CNS Drugs Journal subject: FARMACOLOGIA / NEUROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2022 Document type: Article Affiliation country: Switzerland Country of publication: New Zealand

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Sclerosis Type of study: Prognostic_studies Limits: Adult / Humans Language: En Journal: CNS Drugs Journal subject: FARMACOLOGIA / NEUROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2022 Document type: Article Affiliation country: Switzerland Country of publication: New Zealand